PMC:7200337 / 6312-6543 JSONTXT

{"project":"2_test","denotations":[{"id":"32505227-20020050-46575211","span":{"begin":0,"end":4},"obj":"20020050"},{"id":"32505227-19380580-46575212","span":{"begin":18,"end":22},"obj":"19380580"},{"id":"32505227-17715225-46575213","span":{"begin":41,"end":45},"obj":"17715225"},{"id":"T21841","span":{"begin":0,"end":4},"obj":"20020050"},{"id":"T20061","span":{"begin":18,"end":22},"obj":"19380580"},{"id":"T44255","span":{"begin":41,"end":45},"obj":"17715225"}],"text":"2009, Siu et al., 2009, Wathelet et al., 2007). SARS-CoV-2 likely achieves a similar effect, as suggested by the lack of robust type I/III IFN signatures from infected cell lines, primary bronchial cells, and a ferret model (Blanco"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T45987","span":{"begin":168,"end":172},"obj":"Body_part"},{"id":"T57688","span":{"begin":198,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A60437","pred":"fma_id","subj":"T45987","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A5781","pred":"fma_id","subj":"T57688","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"2009, Siu et al., 2009, Wathelet et al., 2007). SARS-CoV-2 likely achieves a similar effect, as suggested by the lack of robust type I/III IFN signatures from infected cell lines, primary bronchial cells, and a ferret model (Blanco"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T55","span":{"begin":48,"end":56},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"2009, Siu et al., 2009, Wathelet et al., 2007). SARS-CoV-2 likely achieves a similar effect, as suggested by the lack of robust type I/III IFN signatures from infected cell lines, primary bronchial cells, and a ferret model (Blanco"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T51305","span":{"begin":75,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T41210","span":{"begin":168,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0000031"},{"id":"T80754","span":{"begin":198,"end":203},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T25559","span":{"begin":209,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T98223","span":{"begin":211,"end":217},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9669"}],"text":"2009, Siu et al., 2009, Wathelet et al., 2007). SARS-CoV-2 likely achieves a similar effect, as suggested by the lack of robust type I/III IFN signatures from infected cell lines, primary bronchial cells, and a ferret model (Blanco"}

{"project":"LitCovid-PubTator","denotations":[{"id":"219","span":{"begin":48,"end":58},"obj":"Species"},{"id":"220","span":{"begin":211,"end":217},"obj":"Species"},{"id":"224","span":{"begin":159,"end":167},"obj":"Disease"}],"attributes":[{"id":"A219","pred":"tao:has_database_id","subj":"219","obj":"Tax:2697049"},{"id":"A220","pred":"tao:has_database_id","subj":"220","obj":"Tax:9669"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"2009, Siu et al., 2009, Wathelet et al., 2007). SARS-CoV-2 likely achieves a similar effect, as suggested by the lack of robust type I/III IFN signatures from infected cell lines, primary bronchial cells, and a ferret model (Blanco"}